Prophylactic Antibiotics to Reduce Morbidity and Mortality in Newborn Infants with Intercostal Catheters (Review)

Total Page:16

File Type:pdf, Size:1020Kb

Prophylactic Antibiotics to Reduce Morbidity and Mortality in Newborn Infants with Intercostal Catheters (Review) Cochrane Database of Systematic Reviews Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters (Review) Stewart A, Inglis GDT, Jardine LA, Koorts P, Davies MW Stewart A, Inglis GDT, Jardine LA, Koorts P, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008173. DOI: 10.1002/14651858.CD008173.pub2. www.cochranelibrary.com Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters (Review) Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 BACKGROUND .................................... 2 OBJECTIVES ..................................... 3 METHODS ...................................... 3 RESULTS....................................... 5 DISCUSSION ..................................... 6 AUTHORS’CONCLUSIONS . 6 REFERENCES ..................................... 6 CHARACTERISTICSOFSTUDIES . 8 DATAANDANALYSES. 10 HISTORY....................................... 10 CONTRIBUTIONSOFAUTHORS . 10 DECLARATIONSOFINTEREST . 10 SOURCESOFSUPPORT . 10 INDEXTERMS .................................... 10 Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters (Review) i Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Intervention Review] Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters Alice Stewart1, Garry DT Inglis2, Luke A Jardine3, Pieter Koorts4, Mark W Davies2 1Monash Newborn, Monash Medical Centre, Clayton, Australia. 2Grantley Stable Neonatal Unit, Royal Brisbane and Women’s Hospital, Department of Paediatrics & Child Health, The University of Queensland, Brisbane, Australia. 3Department of Neonatology, Mater Mother’s Hospital, Mater Medical Research Institute, The University of Queensland, South Brisbane, Australia. 4Grantley Stable Neonatal Unit, Royal Brisbane and Women’s Hospital, Brisbane, Australia Contact address: Alice Stewart, Monash Newborn, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria, 3158, Australia. [email protected]. Editorial group: Cochrane Neonatal Group. Publication status and date: New, published in Issue 4, 2012. Review content assessed as up-to-date: 16 June 2011. Citation: Stewart A, Inglis GDT, Jardine LA, Koorts P, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008173. DOI: 10.1002/14651858.CD008173.pub2. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ABSTRACT Background Intercostal catheters are commonly used for the drainage of intrathoracic collections in newborn infants, including pneumothorax and pleural effusions. Placement of an intercostal drain is a potential risk factor for nosocomial infection due to breach of the cutaneous barrier. Therefore, neonates who require intercostal drainage, especially those in high risk groups for nosocomial infection, may benefit from antibiotic prophylaxis. However, injudicious antibiotic use carries the risk of promoting the emergence of resistant strains of micro-organisms or of altering the pattern of pathogens causing infection. Objectives To determine the effect of prophylactic antibiotics compared to selective use of antibiotics on mortality and morbidity (especially septicaemia) in neonates undergoing placement of an intercostal catheter. Search methods The standard search strategy of the Cochrane Neonatal Review Group was used to search the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 5), MEDLINE (1948 to June 2011) and CINAHL (1982 to June 2011). Selection criteria Randomised controlled trials or some types of non-randomised (that is, quasi-randomised) controlled trials of adequate quality in which either individual newborn infants or clusters of infants were randomised to receive prophylactic antibiotics versus placebo or no treatment. Data collection and analysis We used the standard methods of the Cochrane Neonatal Review Group. Main results We did not find any randomised controlled trials that met the eligibility criteria. Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters (Review) 1 Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Authors’ conclusions There are no data from randomised trials to either support or refute the use of antibiotic prophylaxis for intercostal catheter insertion in neonates. Any randomised controlled trials of antibiotic prophylaxis would need to account for the fact that neonates who require insertion of an intercostal catheter may already be receiving antibiotics for other indications. PLAIN LANGUAGE SUMMARY Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters There is no evidence to support or refute the use of preventive antibiotics in newborn babies with drainage tubes placed in the chest. Sick newborn babies occasionally need the insertion of a tube that is placed through the skin and into the lung space to drain air or fluid from around their lungs. Because this process involves breaching the skin barrier, there is a potential risk of infection. The group of babies most likely to need this procedure are also those that are most at risk of developing an infection during their stay in hospital. Preventive antibiotics are commonly used when there is a risk of infection, but they may have unwanted effects. The review authors found no evidence to support or refute the use of routine preventive antibiotics when intercostal catheters are inserted in newborn babies. BACKGROUND longed duration and increased severity of respiratory illness (in- cluding chronic lung disease and the need for respiratory sup- port) (Greenough 2005), increased length of hospital stay (Mireya Description of the condition 2007) and impaired neurodevelopmental outcomes (Stoll 2004). Documented complications of intercostal catheters in both pae- Intercostal catheters are commonly used for the drainage of in- diatric and adult populations include localised cellulitis (Margau trathoracic collections in newborn infants, including pneumoth- 2006) and empyema (Bailey 2000). The incidence of empyema orax and pleural effusions. Placement of intercostal catheters is following intercostal drainage has been reported at about 2% common in critically ill neonates, especially in infants with birth- (Millikan 1980; Chan 1997; Bailey 2000). Potential factors to be weight less than 1500 g (very low birth weight infants, VLBW). implicated in infection of the drain site and pleural space include The Vermont Oxford Network Database reported an incidence failure of the aseptic technique, advancement of a pre-existing of pneumothorax in VLBW infants ranging from 5.1% to 8.6% drain into the pleural space and duration of intercostal drainage (1991 to 1996) (Horbar 2002). (Tang 2002). Factors that might affect the risk of infection, in- As with any procedure involving breach of the cutaneous barrier, cluding geographic location of insertion (operating theatre, inten- intercostal drainage is a potential risk factor for nosocomial infec- sive care unit, retrieval site), patient acuity at the time of catheter tion. Additionally, by virtue of their underlying illness, patients re- placement, and the skill level of the operator, have been incom- quiring intercostal catheters may have impaired local and systemic pletely studied (Baumann 2003). defence mechanisms. Premature and low birth weight infants are There are currently no published recommendations on the use of particularly at risk. Retrospective data from the National Institute prophylactic antibiotics for intercostal catheters for non-traumatic of Child Health and Development (NICHD) Neonatal Research indications. In adult chest trauma patients requiring intercostal Network, USA, demonstrated an incidence of pneumothorax from drainage, several studies have found evidence of benefit from sin- 1990 to 2002 of 13% in infants weighing 501 to 750 g and 6% gle-dose antimicrobial prophylaxis (Grover 1977; LeBlanc 1985; in infants weighing 751 to 1000 g (Fanaroff 2007). In these same Demetriades 1991) and published evidence-based guidelines for populations, the incidence of late-onset septicaemia was 44% and chest trauma make a level III recommendation (based on class I 30% respectively. Hence, the group of premature neonates most and II data) for up to 24 hours of cover with a first generation likely to require an intercostal catheter are also those most at risk cephalosporin (Luchette 2000). However, for non-traumatic indi- of morbidity and mortality as a result of nosocomial infection. cations across all age groups there remains variability in practice, Infection secondary to the use of intercostal catheters may cause including the timing, target population and choice of antibiotics. significant morbidity and mortality. Morbidity may include pro- Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters (Review) 2 Copyright © 2012 The Cochrane Collaboration. Published by John Wiley
Recommended publications
  • Pediatric Chest Tubes and Pigtails
    November 2015 Pediatric Chest Tubes And Volume 12, Number 11 Authors Pigtails: An Evidence-Based Jonathan Strutt, MD Pediatric Emergency Department, Children’s Hospital and Clinics of Minnesota, Minneapolis, MN Approach To The Management Anupam Kharbanda, MD, MSc Research Director, Associate Fellowship Director, Department of Pediatric Emergency Medicine, Children's Hospitals and Clinics of Of Pleural Space Diseases Minnesota, Minneapolis, MN Peer Reviewers Abstract Jennifer Mitzman, MD Assistant Professor of Emergency Medicine, The Ohio State Pediatric thoracostomy procedures are used in the emergency depart- University Wexner Medical Center; Assistant Professor of Pediatrics, Nationwide Children’s Hospital, Columbus, OH ment to treat diseases of the pleural space. As children have unique Emily Rose, MD, FAAP, FAAEM, FACEP thoracic anatomy and physiology, they may present with manage- Assistant Professor of Clinical Emergency Medicine, Keck School of ment challenges that the emergency clinician must consider. This Medicine of the University of Southern California, LA County + USC Medical Center, Los Angeles, CA issue reviews the use of chest tubes and pigtail catheters in pediatric CME Objectives patients, techniques and indications for placement, and possible complications. Diagnostic and treatment options for diseases of the Upon completion of this article, you should be able to: 1. Diagnose pleural space disease based on signs and pleural space, such as spontaneous pneumothorax, traumatic injury, symptoms. and parapneumonic effusions/empyema, are examined. Addition- 2. Choose the most effective imaging studies to aid in diagnosis. 3. Determine the types of procedural interventions necessary in ally, this issue discusses the use of imaging modalities to aid in the pleural space disease and when they should be performed.
    [Show full text]
  • Suturing with U-Technique Versus Un
    Official Title of the Study: Suturing with U-Technique versus Un- Reapproximated wound Edges during removal of Closed Thoracostomy-tube drain - A single centre Open-label randomized prospective trial (SUTURE TRIAL) NCT NUMBER: Not Yet Assigned DATE OF DOCUMENT: January 16, 2019 1 STUDY SUMMARY Title: Suturing with U-Technique versus Un-Reapproximated wound Edges during removal of Closed Thoracostomy-tube drain - A single centre Open-label randomized prospective trial (SUTURE TRIAL) Background: Closed thoracostomy tube drainage or chest tube insertion is one of the most commonly performed procedures in thoracic surgery. There are several published evidence-based guidelines on safe performance of a chest tube insertion. However, there is absence of prospective controlled trials or systematic reviews indicating the safest technique of closing the wound created at the time of chest tube insertion and that best guarantees good wound and overall outcomes, post-chest tube removal. The use of a horizontal mattress non-absorbable suture or U- suture which is placed at the time of chest tube insertion and used to create a purse-string wound re-approximation at the time of tube removal has been an age-long and time-honored practice in most thoracic surgical settings. It has been established by a recent study that an occlusive adhesive-absorbent dressing can also be safely used to occlude the wound at the time of chest tube removal with good wound and overall outcomes though the study focused on tubes inserted during thoracic surgical operations.
    [Show full text]
  • Thoracostomy Tube Complications and Pitfalls: an Experience at a Tertiary Level Military Hospital
    Original Article Thoracostomy tube complications and pitfalls: an experience at a tertiary level military hospital Mohammad I. Al-Tarshihi, Fawaz A. Khamash, Abd Ellatif O. Al Ibrahim From Division of Thoracic Surgery, King Hussein Medical Center, Royal Medical Services. Amman, Jordan Correspondence: Mohammad Al-Tarshihi, MD PO Box: 855003 Amman 11855 Jordan Telephone: +962 795542420 Email: [email protected] Received: February 29, 2008 Accepted: April 22, 2008 ABSTRACT Objective: To describe possible complications of thoracostomy tube insertion and common pitfalls regarding the management of the under water seal system. Methods: This descriptive study was conducted at King Hussein Medical Center of the Royal Medical Services between December 2006 and January 2008. Two hundred twenty four patients were included in this study with 339 tube insertions. Complications related to the thoracostomy tube insertion and mistakes practiced by the medical staff regarding the management of thoracostomy tube and its system were documented and analyzed. 1 Results: There were 131 males (58.5%) and 93 females (41.5%). Age ranged from 15 to 86 years (mean 41±10.11). One hundred seventy one thoracostomy tubes (50.4%) were inserted in the operating theater post thoracotomy or thoracoscopic surgery, 99 (29.2%) were inserted in the intensive care unit and surgical wards, while 69 (20.4%) were inserted in the emergency department. The most common complications related to chest tube insertion were lung injury followed by intercostal vessels injury. The commonest mistakes related to the care of thoracostomy tube and its system were tube clamping during the transport of the patients, and improper handling of the negative suction system connected to the chest bottle.
    [Show full text]
  • Evaluation of Percutaneous Tube Thoracostomy Performed By
    Bangladesh Crit Care J March 2021; 9 (1): 28-33 Original Article Evaluation of Percutaneous tube Thoracostomy Performed by Trainee in both Trauma and non-Trauma Patients Kulsum Maula*1, Md Kamrul Alam2, Md Ibrahim Khalil3, Md Nazmul Hasan4, Mohammad Omar Faruq5 DOI: https://doi.org/10.3329/bccj.v9i1.53053 Abstract: Background: Percutaneous Tube Thoracostomy (PTT) is an invasive procedure that can save life now and then in different traumatic and non-traumatic conditions. But still it is an enigma; how our trainee surgeons are at home in this procedure. Objectives: To evaluate the outcome of the percutaneous tube thoracostomy performed by trainee in both trauma and non-trauma patients. Study design: Prospective, Observational study. Duration of study was September, 2019 to February, 2019. Methods: All patients who need PTT in traumatic and non-traumatic conditions were selected by purposive sampling. Thereafter, they were scrutinized according to eligibility criteria and 96 patients were finalized. A pre-tested, observation based, peer-reviewed data collection sheet was prepared before study. Data regarding clinical and surgical outcome profile were recorded. Data were compiled, edited, analyzed. Results: Among 96 patients, the highest 32.29% belonged to age group 31-40 years and lowest 9.37% belonged to age group ≤20. The mean age of the respondents was 29.19±9.81. We found out of 96 patients, 70(72.91%) were indicated PTT for traumatic conditions and rest 26(27.08%) were indicated PTT for non-traumatic chest condition where 36(37.5%) had simple penumothorax, 21(21.87%) haemothorax, 14(14.58%) massive pleural effusion, 13(13.54%) tension pneumothorax, 10(10.41%) haemopneumothorax, and 2(2.08%) had pyothorax respectively.
    [Show full text]
  • Thoracostomy Tube Irrigation: a Multi-Center Trial Investigating Its Efficacy in the Reduction of Secondary Intervention for the Management of Retained Hemothorax
    Thoracostomy Tube Irrigation: A Multi-Center Trial Investigating its Efficacy in the Reduction of Secondary Intervention for the Management of Retained Hemothorax Study Protocol 11/27/2019 Principal Investigator: Thomas Carver M.D. Co-Investigators: Kelly Boyle M.D., Nathan Kugler M.D., & Marc de Moya M.D. Research Coordinator: Amber Brandolino, M.S. Page 1 of 8 Lead Site and Principal Investigator: Medical College of Wisconsin, Milwaukee, WI Thomas W. Carver, MD Purpose: Tube thoracostomy (TT) is the most common procedure performed to treat traumatic pneumothorax (PTx), hemothorax (HTx), and hemopneumothorax (HPTx).1 While the majority of hemothoraces are successfully managed with TT placement, retained HTx may occur in up to 20% of patients, resulting in significant morbidity and mortality.2-8 There is abundant research on the optimal management of retained collections,9-17 however, few studies have focused on prevention of retained hemothorax. A pilot study using thoracic irrigation performed at the time of TT placement resulted in fewer secondary interventions for retained hemothorax.22 This was expanded to a single institution prospective comparative study that yielded similar findings. Based on these promising results, it is necessary to validate the efficacy of thoracic cavity irrigation to prevent retained HTx requiring secondary intervention in a larger, multi-institutional patient population. Background: Most thoracic trauma resulting in the formation of pneumothorax (PTx), hemothorax (HTx), or hemopneumothorax (HPTx) is successfully managed with thoracostomy tube (TT) placement to evacuate blood and / or air from the pleural space.1 Thoracostomy tubes have been a staple of hemothorax management for years, with successful management remaining stable at 80% for decades.2-5 When TT fails, however, the resulting retained collection can lead to complications such as empyema and fibrothorax.3,6-8 A majority of thoracic trauma research has focused on the timing and treatment of these retained collections.
    [Show full text]
  • STANDARDIZED PROCEDURE CHEST TUBE PLACEMENT (Adult)
    STANDARDIZED PROCEDURE CHEST TUBE PLACEMENT (Adult) I. Definition Chest tube insertion is a common therapeutic procedure used to provide evacuation of abnormal collections of air or fluid from the pleural space. Tube thoracostomy may be indicated for pleural effusions associated with malignancy, infection, or hemothorax in the post-surgical setting. In these situations, drainage is imperative to allow for lung re- expansion. II. Background Information A. Setting: The setting (inpatient vs outpatient) and population (adults vs pediatrics) for the Advanced Health Practitioner (AHP) is determined by the approval of the privileges requested on the AHP Privilege Request Form. This particular procedure is for adults only. B. Supervision The necessity of the procedure will be determined by the AHP in verbal collaboration with the attending physician or his/her designee. Direct supervision is necessary until competency is determined and the minimum number of procedures is successfully completed, as provided for in the procedure. After that time, the attending physician or his/her designee must be available. Designee is defined as another attending physician who works directly with the supervising physician and is authorized to oversee the procedures being done by the AHP. C. Indications 1. Pneumothorax (especially if it is large or progressive, or if the patient is symptomatic). 2. Tension pneumothorax. 3. Penetrating chest trauma. 4. Hemothorax. 5. Chylothorax 6. Empyema. 7. Drainage of pleural effusions. 8. Prevention of hydrothorax after cardiothoracic surgery. 9. Bronchopleural fistula D. Precautions/Contraindications 1. Anticoagulation of a bleeding dyscrasia. 2. Systemic anticoagulation. 3. Small, stable pneumothorax (may spontaneously resolve). 1 STANDARDIZED PROCEDURE CHEST TUBE PLACEMENT (Adult) 4.
    [Show full text]
  • Intrapleural Fibrinolysis in Clotted Haemothorax Agarwal R, Aggarwal a N, Gupta D
    Case Report Singapore Med J 2006; 47(11) : 984 Intrapleural fibrinolysis in clotted haemothorax Agarwal R, Aggarwal A N, Gupta D ABSTRACT Although thoracotomy is an effective procedure The immediate treatment of haemothorax in the management of clotted haemothorax, is thoracostomy tube insertion. One currently, minimal invasive procedures are preferred complication of haemothorax is retained to open thoracotomy. Video-assisted thoracoscopic blood and if improperly managed, this can surgery (VATS) is currently regarded as the best lead to complications such as empyema and available modality for the management of clotted fibrothorax. The ideal management of clotted haemothorax(1). However, VATS is not routinely haemothorax is a matter of controversy. available in many centres, and is not without Video-assisted thoracoscopic surgery (VATS) complications. Another easy, widely-available and is believed to be the best available modality effective alternative to surgical management is for the management of clotted haemothorax. intrapleural fibrinolysis using streptokinase(3). In However, VATS is not routinely available this article, we report the successful management in many centres. One easily available and of a patient with clotted haemothorax, and review effective alternative to VATS is the use the literature on the current management of clotted of intrapleural fibrinolysis. We report the haemothorax. successful management of a post-traumatic clotted haemaothorax in a 34-year-old man, CASE REPORT using intrapleural instillation of streptokinase, A 34-year-old previously-healthy man presented with and review the literature on the management history of chest pain and breathlessness of one-day of clotted haemothorax. duration. There was a history of blunt chest trauma Keywords: clotted haemothorax, haemothorax, following a roadside accident when his car steering intrapleural fibrinolysis, intrapleural wheel had hit his chest.
    [Show full text]
  • Management of Anticoagulant and Antiplatelet Therapy in Patients Undergoing Interventional Pulmonary Procedures
    REVIEW ANTITHROMBOTIC AGENTS Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures Vikas Pathak1, J. Erin Allender2 and Mollie W. Grant2 Affiliations: 1Dept of Pulmonary Disease and Critical Care Medicine, WakeMed Health and Hospitals, Raleigh, NC, USA. 2Dept of Pharmacy, WakeMed Health and Hospitals, Raleigh, NC, USA. Correspondence: Vikas Pathak, Pulmonary and Critical Care Medicine, WakeMed Health and Hospitals, Raleigh, NC 27610, USA. E-mail: [email protected] @ERSpublications Available studies suggest some antithrombotic agents may be used in interventional pulmonary procedures http://ow.ly/vSF030bRqjt Cite this article as: Pathak V, Allender JE, Grant MW. Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures. Eur Respir Rev 2017; 26: 170020 [https://doi.org/10.1183/16000617.0020-2017]. ABSTRACT There has been great progress in antithrombotic therapy over the past several years. Its use has increased with the advent of novel anticoagulants, as these medications do not require frequent blood tests for monitoring. Antithrombotic therapy is aimed at reducing the risk of thromboembolic events in patients with atrial fibrillation, coronary artery disease, deep vein thrombosis, valvular heart disease and pulmonary embolism. These patients are often critically ill and frequently undergo urgent interventions requiring discontinuation of anticoagulant or antiplatelet therapy which can increase the risk of thrombosis; however, continuing these agents can lead to increased risk of haemorrhage. The purpose of this article is to summarise the literature surrounding the safety of using antiplatelet and anticoagulant therapies in patients undergoing interventional pulmonary procedures. Introduction Interventional pulmonology is an evolving field that encompasses the management of pulmonary diseases through a minimally invasive approach [1].
    [Show full text]
  • A Systematic Review and Meta-Analysis Comparing Pigtail Catheter and Chest Tube As the Initial Treatment for Pneumothorax
    [ Original Research Pulmonary Procedures ] A Systematic Review and Meta-Analysis Comparing Pigtail Catheter and Chest Tube as the Initial Treatment for Pneumothorax Su-Huan Chang, MD; Yi-No Kang, MA; Hsin-Yi Chiu, MD; and Yu-Han Chiu, MD, ScD BACKGROUND: The optimal initial treatment approach for pneumothorax remains contro- versial. This systemic review and meta-analysis investigated the effectiveness of small-bore pigtail catheter (PC) drainage compared with that of large-bore chest tube (LBCT) drainage as the initial treatment approach for all subtypes of pneumothorax. METHODS: PubMed and Embase were systematically searched for observational studies and randomized controlled trials published up to October 9, 2017, that compared PC and LBCT as the initial treatment for pneumothorax. The investigative outcomes included success rates, recurrence rates, complication rates, drainage duration, and hospital stay. RESULTS: Of the 11 included studies (875 patients), the success rate was similar in the PC (79.84%) and LBCT (82.87%) groups, with a risk ratio of 0.99 (95% CI, 0.93 to 1.05; I2 ¼ 0%). Specifically, PC drainage was associated with a significantly lower complication rate following spontaneous pneumothorax than LBCT drainage (Peto odds ratio: 0.49 [95% CI, 0.28 to 0.85]; I2 ¼ 29%). In the spontaneous subgroup, PC drainage was associated with a signifi- cantly shorter drainage duration (mean difference, À1.51 [95% CI, À2.93 to À0.09]) and hospital stay (mean difference: À2.54 [95% CI, À3.16 to À1.92]; P < .001) than the LBCT group. CONCLUSIONS: Collectively, results of the meta-analysis suggest PC drainage may be considered as the initial treatment option for patients with primary or secondary sponta- neous pneumothorax.
    [Show full text]
  • Chest Tube Placement (Thoracostomy) and Pleurodesis Thoracostomy Involves the Insertion of a Thin Plastic Tube Into the Space Between the Lungs and the Chest Wall
    Chest Tube Placement (Thoracostomy) and Pleurodesis Thoracostomy involves the insertion of a thin plastic tube into the space between the lungs and the chest wall. The tube may be attached to a suction device to remove excess fluid or air. Or, it may be used in a procedure called pleurodesis in which medication is delivered into the space to decrease the likelihood that fluid will accumulate. Thoracostomy may be performed to treat pneumothorax, also known as collapsed lung. Your doctor will instruct you on how to prepare, including any changes to your medication schedule. Tell your doctor if there's a possibility you are pregnant and discuss any recent illnesses, medical conditions, allergies and medications you're taking, including herbal supplements and aspirin. You may be advised to stop taking aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) or blood thinners several days prior to your procedure. Leave jewelry at home and wear loose, comfortable clothing. You may be asked to wear a gown. What is chest tube placement (thoracostomy) and pleurodesis? Thoracostomy is a minimally invasive procedure in which a thin plastic tube is inserted into the pleural space — the area between the chest wall and lungs — and may be attached to a suction device to remove excess fluid or air. A chest tube may also be used to deliver medications into the pleural space. Imaging techniques such as computed tomography (CT), fluoroscopy and ultrasound (US) may be used to help guide the interventional radiologist's instruments while placing the chest tube. Two thin membranes line the pleural space — one wraps around the lungs and another lines the inner wall of the chest.
    [Show full text]
  • Tube Thoracostomy During the COVID-19 Pandemic
    Open access Guidelines/Algorithms Trauma Surg Acute Care Open: first published as 10.1136/tsaco-2020-000498 on 30 April 2020. Downloaded from Tube thoracostomy during the COVID-19 pandemic: guidance and recommendations from the AAST Acute Care Surgery and Critical Care Committees Fredric M Pieracci,1 Clay Cothren Burlew,1 David Spain,2 David H Livingston,3 Eileen M Bulger,4 Kimberly A Davis ,5 Christopher Michetti 6 1Department of Surgery, Denver ABSTRact likelihood of successful tube placement. If creation Health, Denver, Colorado, USA of a formal thoracic procedure team is not logis- 2 This document provides guidance for trauma and acute Department of Surgery, tically possible, strong consideration should be Stanford University, Stanford, care surgeons surrounding the placement, management California, USA and removal of chest tubes during the COVID-19 given to limiting the number of both providers and 3Department of Surgery, pandemic. specialists performing tube thoracostomy. Rutgers, New Brunswick, New Jersey, USA 4Department of Surgery, CREatION OF AN INSTITUTIONAL ALGORITHM University of Washington, BACKGROUND FOR THORacIC PROCEDURES Seattle, Washington, USA It is recommended that each institution create a 5 Tube thoracostomy for a traumatic hemothorax or Department of Surgery, Yale standard algorithm for handling thoracic proce- School of Medicine, New Haven, pneumothorax is a potentially aerosol- generating Connecticut, USA procedure that is performed frequently by acute dures based on their resources and expertise. The 6Department of Surgery, Inova care surgeons. There are no data specific to the algorithm should include stratification of both Fairfax Medical Center, Falls aerosolization of the severe acute respiratory procedure urgency and patient risk of COVID-19.
    [Show full text]
  • NEEDLE ASPIRATION) (Neonatal, Pediatric)
    STANDARDIZED PROCEDURE NEONATAL / PEDIATRIC THORACENTESIS (NEEDLE ASPIRATION) (Neonatal, Pediatric) I. Definition To insert a needle into the chest in order to evacuate air or fluid II. Background Information A. Setting: Inpatient neonatal / pediatric patients or outpatient during Emergency Transport of neonatal / pediatric patients. If appropriate, implement procedural support, if available- make sure Child Life is involved, and use age appropriate language and age appropriate developmental needs with care of children B. Supervision The necessity of the procedure will be determined by the Advanced Health Practitioner (AHP) in verbal collaboration with the attending physician or his/her designee. Ideally, the procedure will first be verbally discussed with the Attending Physician or Fellow, but if time does not permit for that, then the Attending or Fellow is to be notified as soon as possible after the procedure. Direct supervision is necessary until competency is determined and the minimum number of procedures is successfully completed, as provided for in the protocol. After that time, the attending physician or his/her designee must be available. Designee is defined as another attending physician or fellow who works directly with the supervising physician and is authorized to oversee the procedures being done by the AHP. C. Indications Decompression of tension pneumothorax or fluid accumulation (pleural effusions, chylothorax, empyema) in order to allow adequate lung expansion for ventilation. In an acute emergency, needle aspiration should be performed if the baby's cardiopulmonary status is unstable. After an emergency needle aspiration has been performed, a thoracotomy tube should be inserted. D. Precautions/Contraindications 1. When the patient’s vital signs are stable enough to allow placement of thoracostomy tube instead.
    [Show full text]